Avery Orrall

Weekend reads: ‘Lack of informed consent’ in DNA data; protecting the ‘prey’ of predatory journals; another ivermectin-COVID-19 retraction

The week at Retraction Watch featured:

Meet Retraction Watch’s two new journalists
Elsevier denies AI use in response to evolution journal board resignations
Biotech company agrees to pay $4 million to settle data falsification allegations
Science paper by Toronto lab retracted
The 14 universities with publication metrics researchers say are too good to be true

Our list of retracted or withdrawn COVID-19 papers is up past 450. There are more than 50,000 retractions in The Retraction Watch Database — which is now part of Crossref. The Retraction Watch Hijacked Journal Checker now contains more than 300 titles. And have you seen our leaderboard of authors with the most retractions lately — or our list of top 10 most highly cited retracted papers? What about The Retraction Watch Mass Resignations List — or our list of nearly 100 papers with evidence they were written by ChatGPT?

Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):

The 14 universities with publication metrics researchers say are too good to be true

Saveetha Institute of Medical and Technical Sciences

More than a dozen universities have used “questionable authorship practices” to inflate their publication metrics, authors of a new study say. One university even saw an increase in published articles of nearly 1,500% in the last four years.

The study, published January 5 in Quantitative Science Studies, “intends to serve as a starting point for broader discussions on balancing the pressures of global competition with maintaining ethical standards in research productivity and authorship practice,” study authors Lokman Meho and Elie Akl, researchers at the American University of Beirut in Lebanon, told Retraction Watch.

Science paper by Toronto lab retracted

Anomalies in Figure 1 of a 2014 *Science* paper, a portion of which is shown here, is one of several in question in a retraction published in the January 10 *Science*. *Source*

A 2014 paper in Science by a lab in Toronto has been retracted after a December expression of concern raised “potential data integrity issues.”

The paper, “Mitosis Inhibits DNA Double-Strand Break Repair to Guard Against Telomere Fusions,” is from the lab of Daniel Durocher, a professor of molecular genetics at the University of Toronto.

The retraction notice, published today and signed by all of the original authors, reads, in part:

First paper retracted in string of studies using the wrong medication name

A scientific sleuth and a mother who nearly lost her daughter to a hormonal condition teamed up in January to flag a series of papers that misnamed a medication for pregnant women. They have recently started to see the fruits of their labors: one retraction and three corrections.

In 2014, Tara Skopelitis, a lab manager at Cold Spring Harbor Laboratory, was given weekly progesterone injections to prevent preterm birth for her daughter, as reported by STAT. Six years later, after her daughter showed symptoms of an unknown hormonal condition which still hasn’t been formally diagnosed, Skopelitis discovered she should have received synthetic progesterone variant 17α-hydroxyprogesterone caproate, often referred to as 17-OHPC, 17P, sold as Makena. When the drug wasn’t available, her doctor had ordered the wrong replacement from a compounding pharmacy. Skopelitis suspects her daughter’s condition could be a result of the mixup.

The confusion lies within the literature, Skopelitis says: Many clinical trials and papers refer to 17P as intramuscular progesterone, as if they are interchangeable or even the same compound.

Researcher whose work was plagiarized haunted by impostor emails

A researcher who posted on LinkedIn about a paper that plagiarized his work says he’s now the subject of an email campaign making false allegations about his articles.

In July, we reported that Sasan Sadrizadeh, researcher at KTH Royal Institute of Technology in Stockholm, had his work plagiarized in a now-retracted paper.

“In what seems to be a direct response to our efforts,” as Sadrizadeh wrote in a recent LinkedIn post, his bosses, colleagues, and journals have been inundated with emails from impostors, accusing Sadrizadeh of misuse of funds and calling for the removal of his articles. At least one journal editor seems to have taken the allegations seriously.

Journal retracts article for plagiarized images after trying to gag researcher who complained

The journal Cureus retracted an article for plagiarized images after questioning the motives of the researcher who said her images were taken.

The researcher, who asked to remain anonymous, first emailed Cureus, an open-access journal Springer Nature acquired in 2022, on August 1. She said she noticed images in the October 2023 paper, “Pediatric Acute Dacryocystitis and Orbital Cellulitis With Concurrent COVID-19 Infection: A Case Report,” came from a lecture she posted online and later removed.

“The images used in this article were edited and presented under a fabricated clinical scenario” and had been used without her permission, the researcher wrote in an email seen by Retraction Watch. She requested the journal retract the article. She also provided what she said were her original images, which were replicated in Figure 1 of the paper, and copied the corresponding author of the article.

Sleuths spur cleanup at journal with nearly 140 retractions and counting

A journal that lost its impact factor in June is in the midst of a cleanup operation, issuing nearly 140 retractions so far this year.

The mass retractions began over a year after sleuths Alexander Magazinov and Guillaume Cabanac first raised concerns about the presence of suspicious citations, tortured phrases and undisclosed use of AI in the journal’s articles.

Cabanac and Magazinov have now flagged 1,850 articles from the journal, Springer Nature’s Environmental Science and Pollution Research (ESPR), with the Problematic Paper Screener, which looks for evidence of bad practices in academic papers.

Paper claiming to discover new pain syndrome retracted

Researchers who said they discovered a new disease akin to rheumatoid arthritis, but caused by pollution, are standing by their claim despite the retraction of their paper last month.

The article, “Middle east pain syndrome is a pollution-induced new disease mimicking rheumatoid arthritis,” appeared in the Springer Nature journal Scientific Reports in November 2021. The paper has been cited once, according to Clarivate’s Web of Science, and received limited press coverage.

According to the retraction notice, “post-publication peer review by an expert has confirmed the validity” of multiple concerns raised about the study. The paper did not present data to support its claims about the presumed cause for the syndrome, didn’t “conclusively” prove that MEPS is a new disease, and the bone erosions the study claimed were a hallmark of the disease weren’t backed by scans, the notice stated. Also, a figure of the paper featured a radiograph of a patient that wasn’t part of the study.

Journal republishes chiropractic paper it had retracted after legal threats

A journal has republished an edited version of a paper it retracted after a distributor of a chiropractic product the paper criticized wrote in to complain.

The distributor accused the publication of making “very serious, incorrect and libelous statements” and threatened legal action, Retraction Watch has learned.

Journal retracts paper on chiropractic product after distributor complains

An article about the overuse of spinal imaging has been retracted after the distributor of a chiropractic product it criticized in passing complained to the journal.

The paper, “An investigation into the chiropractic practice and communication of routine repetitive radiographic imaging for the location of postural misalignments,” was retracted in June from the Journal of Clinical Imaging Science after the editor-in-chief learned it contained “controversial statements regarding the commercial product Denneroll,” according to the statement.

Denneroll is a line of support products that purports to help with “spinal remodeling” for people whose spines aren’t curved in the normal way, according to a company brochure. The company’s website states that the Denneroll products are “second to none in spinal orthotics.”

The retraction notice said Deed Harrison, a chiropractor whose family distributes the Denneroll product line, “claimed that the data presented against this product lacks scientific backing.” Harrison’s father, Donald Harrison, originated a technique called Chiropractic BioPhysics (CBP) which is the basis of the Denneroll product line, according to the CBP website.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: